Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Soad K Al Jaouni

Soad K Al Jaouni

King Abdulaziz University, Saudi Arabia

Title: Effect of phoenix dactylifera palm fruit (Ajwa) on Infection, hospitalization, mortality and quality of life among pediatric cancer patients at single Medical Institute in Saudi Arabia

Biography

Biography: Soad K Al Jaouni

Abstract

Background: Recent studies showed that Phoenix dactylifera palm date have beneficial nutritional and medical values.

Objective: To determine the effect of regular intake of Phoenix dactylifera palm date on the occurrence of infections, hospitalization for fever and neutropenia, and mortality of pediatric cancer patients admitted to King Abdulaziz University Hospital, a tertiary care medical center, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.

Methods: A prospective cohort of 56 pediatric cancer patients attending King Abdulaziz University Hospital was enrolled from 2008 to 2015. The effect on quality of life of Ajwa intake with the standard regime of treatment was assessed (number of infections, hospital admissions, and off treatment and mortality) between patients receiving Ajwa supplement and patients not receiving Ajwa supplement. Information regarding demographic, clinicopathologic and treatment options were collected and controlled for accordingly.

Results: Twenty-three patients were on Ajwa and 33 were not on Ajwa. The supplementation of Ajwa significantly reduced hospital admissions (for fever and neutropenia) and infections (P=0.009 and P<0.001 respectively). Off-treatment didn’t significantly differ between Ajwa and non-Ajwa groups. Ajwa group had a better survival in comparison to the non-Ajwa group (stratified log-rank P=0.005), where the main cause of death of patients on the non-Ajwa group was disease progression associated with infections (77%).

Conclusions: Regular intake of Phoenix dactylifera Ajwa supplement showed a significant improvement in the quality of life and mortality rate among pediatric cancer patients. Adding Ajwa to the standard treatment of pediatric cancer patients can improve their treatment outcome.